Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk
about
The TLR9 gene polymorphisms and the risk of cancer: evidence from a meta-analysisThe association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibilityRegulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma.Association of TLR2 and TLR4 polymorphisms with risk of cancer: a meta-analysis.NOD2 polymorphisms associated with cancer risk: a meta-analysis.TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?Association of NOD1 and NOD2 genes polymorphisms with Helicobacter pylori related gastric cancer in a Chinese population.Involvement of Toll-like Receptor 9 polymorphism in cervical cancer developmentPolymorphisms of glutathione S-transferase π 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility.Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients.Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?NOD1 and NOD2 Signaling in Infection and Inflammation.Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer.Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.Two novel susceptibility SNPs for ischemic stroke using exome sequencing in Chinese Han population.Comprehensive assessment of association between TLR4 gene polymorphisms and cancer risk: a systematic meta-analysis.
P2860
Q31131769-A307EAA4-6D93-4CBA-B1C0-A02341CF3299Q34151951-1FF43280-BD96-4EC9-9BFC-567A1145E20BQ34935043-84F85F9D-0969-4069-8B73-AF6427E8DC5FQ35077769-F467EE8C-86EF-405A-8248-DF70D6183A70Q35107083-0ED7065C-C8C0-4B4C-83CE-B0D417D95B3BQ35819527-7D8CA3FC-4D35-4FA7-8485-B46401A20095Q35832150-4DEA59EE-17DA-4F17-BDDA-F2DE5B0643D1Q35929201-1BA2347B-3DAB-43BD-AA12-036791E0D508Q36060845-E3931AD4-3E7B-4DE6-9156-CCD91920361DQ36640368-5C8F2B49-AF90-4552-9C94-2F8C967F3361Q37527855-FCCE3FDA-97A4-4DDF-A35F-1C6D2A346411Q37952071-FFF32075-023B-4E1A-9A98-103B55CBAFB0Q38060719-05FFDF4E-6B18-4322-BA7B-E86494B5C476Q38195472-35074F79-F397-455E-A165-2276BFBE3218Q39378247-798205AF-52C9-4F9E-93F3-DFC312E291E0Q46625668-40C1AFE2-1DE0-430C-87CA-A59B56793840Q47140213-1CA79CA0-DCF4-42F1-B239-241931EE6F00
P2860
Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Toll-like receptor (TLR) and n ...... ms and endometrial cancer risk
@ast
Toll-like receptor (TLR) and n ...... ms and endometrial cancer risk
@en
type
label
Toll-like receptor (TLR) and n ...... ms and endometrial cancer risk
@ast
Toll-like receptor (TLR) and n ...... ms and endometrial cancer risk
@en
prefLabel
Toll-like receptor (TLR) and n ...... ms and endometrial cancer risk
@ast
Toll-like receptor (TLR) and n ...... ms and endometrial cancer risk
@en
P2093
P2860
P356
P1433
P1476
Toll-like receptor (TLR) and n ...... ms and endometrial cancer risk
@en
P2093
Anthony Proietto
Geoffrey Otton
Ian Symonds
John Attia
Katie A Ashton
Mark McEvoy
Rodney J Scott
P2860
P2888
P356
10.1186/1471-2407-10-382
P407
P577
2010-07-21T00:00:00Z
P5875
P6179
1038922200